Lovisa returns to pre-COVID levels on European acquisition

On the back of a European acquisition, Jewellery retailer Lovisa (ASX: LOV) has seen its shares bounce back to levels not seen since the COVID-19 pandemic slamm

Fierce Biotech Fundraising Tracker '23

Poster abstracts, 2023

N-CSR

Mapping the nucleolar proteome reveals a spatiotemporal

Harnessing Nanovaccines for Effective Immunization─A Special

Remote photobiomodulation targeted at the abdomen or legs provides

Economic Bulletin Issue 2, 2021

Class switch toward noninflammatory, spike-specific IgG4

ACP - Relations - Measurement report: The 4-year variability and

N-CSR